BioCentury | Nov 6, 2000
Emerging Company Profile

Infigen: Customized cows and perfect pigs

...human genes into them for expression in the mammary gland. GZTC has production deals with Centocor Diagnostics Inc....
BioCentury | Aug 31, 1998
Company News

Oncor management update

...Hired: James Danehy, as vice-chairman, president and CEO upon his completion of CEO duties with Centocor Diagnostics...
BioCentury | Jun 1, 1998
Company News

Biomira, Centocor Diagnostics deal

...the transfer of BIOMF's Truquant blood test kits for breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...could receive $300,000 in milestones under the asset purchase agreement. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....
BioCentury | Apr 27, 1998
Company News

Centocor diagnostics/imaging news

...CNTO said it is evaluating strategic options for its Centocor Diagnostics subsidiary, including possible sale of the...
...subsidiary, including possible sale of the business, in order to focus on its pharmaceutical business. Centocor Diagnostics...
BioCentury | Apr 6, 1998
Company News

Biomira, Centocor Diagnostics deal

...will sell its Truquant blood test kits to detect breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...operations by Aug. 28, and would lay off 49 employees. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....
BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...bad to terrible," von Emster said. Several companies recently postponed or withdrew offerings - including Centocor Diagnostics...
BioCentury | Dec 22, 1997
Finance

Limping

...down nearly 22 percent since early October), three IPOs fell victim to the soft market. Centocor Diagnostics...
...deals on ice. Illustrating the general malaise in biotech, each deal represented a different territory: Centocor Diagnostics...
...NASDAQ deal, RTP was to price in Canada, and Cerep was in France's Nouveau Marche. Centocor Diagnostics...
BioCentury | Oct 20, 1997
Finance

Attention getting

...consolidation of research programs of Amoco Corp., which will own 63 percent after the IPO. Centocor Diagnostics...
...Centocor (CNTO), filed to raise up to $40 million. CNTO would own 80 percent post-IPO. Centocor Diagnostics...
BioCentury | Oct 20, 1997
Finance

Centocor Diagnostic P&L snapshot

Centocor Diagnostic P&L snapshot 1992 1993 1994 1995 1996 1997 Sales $40,061 $42,386 $36,325 $40,208 $37,611 $24,191 Revenue $41,051 $43,172 $37,133 $42,248 $40,092 $27,637 Net Income $5,596 $7,548 $4,649 $7,685 $5,250 $2,875 BC Staff Diagnostic...
Items per page:
1 - 9 of 9
BioCentury | Nov 6, 2000
Emerging Company Profile

Infigen: Customized cows and perfect pigs

...human genes into them for expression in the mammary gland. GZTC has production deals with Centocor Diagnostics Inc....
BioCentury | Aug 31, 1998
Company News

Oncor management update

...Hired: James Danehy, as vice-chairman, president and CEO upon his completion of CEO duties with Centocor Diagnostics...
BioCentury | Jun 1, 1998
Company News

Biomira, Centocor Diagnostics deal

...the transfer of BIOMF's Truquant blood test kits for breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...could receive $300,000 in milestones under the asset purchase agreement. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....
BioCentury | Apr 27, 1998
Company News

Centocor diagnostics/imaging news

...CNTO said it is evaluating strategic options for its Centocor Diagnostics subsidiary, including possible sale of the...
...subsidiary, including possible sale of the business, in order to focus on its pharmaceutical business. Centocor Diagnostics...
BioCentury | Apr 6, 1998
Company News

Biomira, Centocor Diagnostics deal

...will sell its Truquant blood test kits to detect breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...operations by Aug. 28, and would lay off 49 employees. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....
BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...bad to terrible," von Emster said. Several companies recently postponed or withdrew offerings - including Centocor Diagnostics...
BioCentury | Dec 22, 1997
Finance

Limping

...down nearly 22 percent since early October), three IPOs fell victim to the soft market. Centocor Diagnostics...
...deals on ice. Illustrating the general malaise in biotech, each deal represented a different territory: Centocor Diagnostics...
...NASDAQ deal, RTP was to price in Canada, and Cerep was in France's Nouveau Marche. Centocor Diagnostics...
BioCentury | Oct 20, 1997
Finance

Attention getting

...consolidation of research programs of Amoco Corp., which will own 63 percent after the IPO. Centocor Diagnostics...
...Centocor (CNTO), filed to raise up to $40 million. CNTO would own 80 percent post-IPO. Centocor Diagnostics...
BioCentury | Oct 20, 1997
Finance

Centocor Diagnostic P&L snapshot

Centocor Diagnostic P&L snapshot 1992 1993 1994 1995 1996 1997 Sales $40,061 $42,386 $36,325 $40,208 $37,611 $24,191 Revenue $41,051 $43,172 $37,133 $42,248 $40,092 $27,637 Net Income $5,596 $7,548 $4,649 $7,685 $5,250 $2,875 BC Staff Diagnostic...
Items per page:
1 - 9 of 9